Diagnosis and treatment of the association between thrombotic thrombocytopenic purpura and systemic lupus erythematosus;Porpora trombotica trombocitopenica associata a lupus eritematoso sistemico. Inquadramento clinico-diagnostico e strategie terapeutiche

Recenti Progressi in Medicina

Volumn 91, Issue 10, 2000, Pages 517-531

  Caramaschi, Paola ^a,b   Melchiorri, Silvia ^a   Biasi, Domenico ^a   Carletto, Antonio ^a   Todeschini, Giuseppe ^a   Bambara, Lisa Maria ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b NONE   (Italy)

Author keywords

Systemic lupus erythematosus; Thrombotic thrombocytopenic purpura

Indexed keywords

EID: 0041083293     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Moschowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924; 24: 21.
2. Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States. Analysis of national mortality data, 1968-1991. Am J Haematol 1995; 50: 84-90.
3. Rock GA, Surmak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393-7.
4. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura - hemolytic-uremic syndrome: clinical experience in 108 patents. N Engl J Med 1991; 325: 398-402.
5. Shumak KH, Rock GA, Nair R. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med 1995; 122: 569-72.
6. Kovacs MJ, Roddy J, Gregoire S, Cameron W, Eidus L, Drouin J. Thrombotic thrombocytopenic purpura following hemorragic colitis due to Escherichia coli. Am J Med 1990; 88: 177-9.
7. Kwaan HC. Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 1987; 24: 141-7.
8. Schwartz MI. The obfuscation of eclampsia by thrombotic thrombocytopenic purpura. Obstet Gynecol 1978; 131: 18-24.
9. Mc Shane PM, Bem NM, Schiff I. Thrombotic thrombocytopenic purpura associated with oral contraceptives: a case report. Am J Obstet Gynecol 1983, 145: 762-3.
10. Orbison JL. Morphology of thrombotic thrombocytopenic purpura with demonstrations of aneurysms. Am J Pathol 1952; 28: 129-34.
11. Neame PB, Hirsh J, Browman G, et al. Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption. Can Med Assoc J 1976; 114: 1108-12.
12. Feldman JD, Mardiney MR, Unanue ER, Cutting H. The vascular pathology of thrombotic thrombocytopenic purpura. An immunohistochemical and ultrastructural study. Lab Invest 1966; 15: 927-46.
13. Moake JL. Studies on the pathophysiology of thrombotic thrombocytopenic purpura. Semin Hematol 1997; 34: 83-9.
14. Remuzzi G, Imberti L, De Gaetano G. Prostacyclin deficiency in thrombotic microangiopathies. Lancet 1981; 2: 1422-3
15. Kwaan HC. Role of fibrinolysis in thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24: 101-9.
16. Wada H, Kaneko T, Ohiwa M, et al. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol 1993; 44: 101-5.
17. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 1996; 87-3245-57.
18. Takahashi H, Hanano M, Wada K, et al. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol 1991; 38: 174-7.
19. Kazama M. Clinical evaluation of hemostatic molecular markers. Acta Haematol Jpn 1988; 51: 1387-94.
20. Zeigler ZR, Shadduk RK, Nemuanaitis J, Andrews DF, Rosenfeld CS. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995; 15: 247-53.
21. Chang JC, Shipstone A, Llenado-Leee MA. Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries. Am J Hematol 1996; 53: 11-17.
22. Ucar A, Fernandez HF, Bymes JJ, Lian EC, Harrington WJ jr. Thrombotic microangiopathy and retroviral infections: a 13-year experience. Am J Hematol 1994; 45: 304-9.
23. Wada H, Minami N, Shirakawa S. Cytokine levels in patients with thrombotic thrombocytopenic purpura. Nippon Rinsho Japanese J Clin Med 1993; 51: 151-4.
24. Zauli G, Gugliotta L, Catani L, et al. Increased serum levels of transforming growth factor beta-I in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis. Br J Haematol 1993; 84: 381-6.
25. Wada H, Kaneko T, Ohiwa M, et al. Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 1992; 40: 167-70.
26. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its confirmation and requires calcium ion. Blood 1996; 87: 4235-44.
27. Moore JC, Murphy WG, Kelton JG. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 1990; 74: 457-64.
28. Moake JL, Chow TW. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. Am J Clin Sci 1998; 316: 105-17.
29. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-5.
30. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelet, as well as by exogenous large or unusually large vWF mutimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-74.
31. Wagner DD, Ginsburg D. Structure, biology, and genetics of von Willebrand factor. In: Huffman R et al, (eds). Hematology: Basic principles and practice. New York: Churchill Livingstone, 1995; 1717-25.
32. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums JD. Involvement of large plasma von Willebrand Factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-61.
33. Frangos JA, Moake JL, Nolasco L, Phillips MD, McIntire LV. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am J Physiol 1989; 256: 1635-44.
34. Moake JL. Thrombotic thrombocytopenic purpura. Thromb Haemost 1995; 74: 240-5.
35. Tsai HM, Lian EC-Y. Inibitors to vWf-cleaving metallo-proteinase in thrombotic thrombocytopenic purpura (abstract). Blood 1997: 90(suppl 1): 2620.
36. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P Lammle B. Deficit activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89: 3097-103.
37. Tarantolo SR, Landmark JD, Iwen PC, Kessinger A, Ghang WC, Hinrichs SH. Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura. Lancet 1997; 350: 1602.
38. Gorini M, Luliri P. Steroids: what role in TTP? Transfus Sci 1992; 13: 73-6.
39. Bobbio-Pallavicini E, Porta C, Centurioni R, et al. Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. Eur J Haematol 1994; 52: 222-6.
40. Bird JM, Cummins D, Machin SJ. Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura (letter). Lancet 1990; i: 565-6.
41. Moake JB, Ruay CK, Troll JH, et al. Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathiopririne. Am J Hematol 1985; 20: 73-9.
42. Fessler BJ. Thrombotic syndromes and autoimmune diseases. Rheum Dis Clin North Am 1997; 23: 461-79.
43. Stricker RB, Davis JA, Gershow J, Yamamoto KS, Kiprov DD. Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus. Case report and literature review from the plasmapheresis era. J Rheumatol 1992; 19: 1496-73.
44. Itoh Y, Sekine H, Hosono O, et al. Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus. Clinical significance of anti-platelet antibodies. Clin Immunol Immunopathol 1990; 57: 125-36.
45. Bray VJ, West SG, Kristo DA. Simultaneous presentation of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J 1994; 87: 827-30.
46. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24: 165-72.
47. Dekker A, O'Brien ME, Cammarata RJ. The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus. Am J Med Sci 1974; 267: 243-9.
48. Oen K, Petty RE, Schroeder ML, Briggs EJ, Bishop AJ. Thrombotic thrombocytopenic purpura in a girl with systemic lupus erythematosus. J Rheumatol 1980; 7: 727-9.
49. Gatemby PA, Smith H, Kirvan P, Lauer CS. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. A case report and review of literature. J Rheumatol 1981; 8: 504-8.
50. Cecere FA, Yoshima S, Pope RM. Fatal thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Arthritis Rheum 1981; 24: 550-3.
51. Finkelstein R, Carter A, Markel A, Brook JG. Plasma infusion in thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: a successful outcome. Postgrad Med J 1982; 58: 577-9.
52. Gelfand J, Truong L, Stern L, Pirani CL, Appel GB. Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am J Kidney Dis 1985; 5: 154-60.
53. Becker RC, Giuliani M, Weick JK. Thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Cleve Clin Q 1985; 52: 409-15.
54. Dixit R, Krieg AM, Atkinson JP. Thrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosus. Arthritis Rheum 1985; 28: 341-4.
55. Fox DA, Faix JD, Coblyn J, Fraser P, Smith B, Weinblatt ME. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 319-22.
56. Jonsson OG, Fink CW. Systemic lupus erythematosus presenting as thrombotic thrombocytopenic purpura. J Rheumatol 1990; 17: 973-4.
57. Simeon Aznar CP, Cuenca-Luque R, Fonollosa-Pla V, Bosch-Gil JA. Thrombotic thrombocytopenic purpura preceding systemic lupus erythematosus. Ann Rheum Dis 1992; 396-8.
58. Hess DC, Sethi K, Awad E. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma-exchange and immunosuppression. J Rheumatol 1992; 19: 1474-8.
59. Porta C, Bobbio-Pallavicini E, Centurioni R, Caporali R, Montecucco CM. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. J Rheumatol 1993; 20: 1625-6.
60. Jorfen M, Calleias JL, Formiga F, Cervera R, Font J, Ingelmo M. Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Scand J Rheumatol 1998; 27: 76-7.
61. Caramaschi P, Riccetti MM, Fratta-Pasini A, Savarin T, Biasi D, Todeschini G. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of 3 cases and review of the literature. Lupus 1998; 7: 37-41.
62. Esmon NL, Smirnov MD, Esmon CT. Lupus anticoagulant and thrombosis: the role of phospholipids. Haematologica 1997; 82: 474-7.
63. Arvieux J, Roussel B Pouzol P, Colomb MG. Platelet activating properties of murine monoclonal antibodies to betn-2-glycoprotein I. Thromb Haemost 1993; 70: 336-41.
64. Porta C, Caporali R, Montecucco C, Bobbio-Pallavicini E. Lack of evidence of antineutrophil cytoplasmatic antibodies involvement in the acute phase of thrombotic thrombocytopenic purpura (letter). Nephron 1996; 73: 352-3.
65. Moses J, Lichtman SM, Brody J, Wisch N, Moake JL. Hairy cell leukemia in association with thrombotic thrombocytopenic purpura and factor VIII antibodies. Leuk Lymphoma 1996; 22: 351-4.
66. Koeing DW Barley-Maloney L, Daniel TO. A Western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies. J Clin Immunol 1993; 204-11.
67. Tandon NN Rock G, Jamieson GA. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. Br J Haematol 1994; 88: 816-25.
68. Shepard KV, Bukowski RM. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions and plasma exchange. Semin Hematol 1987; 24: 178-93.
69. Bandarenkc N, Brecher ME and Members of the US TTP Apheresis Study Group. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG). Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apheresis 1988; 13: 133-41.
70. Knobl P, Rintelen C, Kornek G, et al. Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patients. Intensive Care Med 1997; 23: 44-50.
71. Sagripanti A, Carpi A, Rosaia B, et al. Iloprost in the treatment of thrombotic microangiopathy: report of thirteen cases. Biomed Pharmacother 1996; 50: 350-6.
72. Devinsky O. Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988; 23: 380-4.
73. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva D. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992; 20: 150-8.
74. Asherson RA, Khamashta MA, Hughes GRV. Lupus, thrombotic thrombocytopenic purpura and antiphospholipid antibodies. Ann Neurol 1989; 25: 312-3.
75. Dillon MJ, Tizard EJ. Anti-neutrophil cytoplasmic antibodies and antiendothelial cell antibodies. Pediatr Nephrol 1991; 5: 256-9.